← All Sponsors
SPONSOR

New York Medical College

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Non-Hodgkin LymphomaBurkitt LymphomaDiffuse Large B-Cell LymphomaPrimary Mediastinal B-cell LymphomaCD20+ Lymphoblastic LymphomaFollicular Lymphoma, Grade III
NCT02393157 Phase 2
Recruiting

Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL

Non-Hodgkin Lymphoma
United States View Trial →